Organoidsciences Ltd.

₩5,040As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:476040Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (62.29%)
Pharmaceutical Preparations
Beta (5Y) —
PE TTM —
TSR TTM (84.56%)
Mkt cap ₩33.19B
ROIC (24.12%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩6,304
25.08%
86.08%
Buy 2|0|1|12|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
93.94
91.76
91.52
98.54
29.16%
27.99%
14.95%
11.37%
Revenue₩B
4.111
4.129
4.018
3.956
6.17%
6.97%
1.75%
(3.08%)
Peers (US$24.47M)
Cap (US$)
PE
26.80M
6.470x
22.37M
20.31x
24.71M
44.25x
Capital
TTM
5Y
10Y
Leveragex
0.108
0.684
0.570
EBIT/Intx
0.879
0.088
0.086
Own earn%
110.82
125.83
100.25
Sh yield%
21.37
26.21
26.79
Owners
Insiders/Inst%
3.91
29.64
Short interest%
1.15
SBC / revenue%
1.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
24–29
$1 testx
—
Incr. ROIC%
4